Generic placeholder image

Current Drug Therapy

Editor-in-Chief

ISSN (Print): 1574-8855
ISSN (Online): 2212-3903

Research Article

An Approach to Treat Conundrum of Skin Cancer: Bioactive Loaded Niosomes

Author(s): Shikha Srivastava* and Divya Sharma

Volume 18, Issue 4, 2023

Published on: 05 April, 2023

Page: [342 - 349] Pages: 8

DOI: 10.2174/1574885518666230209150126

Price: $65

Abstract

Background: Skin cancer is one of the most life-threatening and progressive diseases nowadays, majorly resulting from the cumulative effect of genetic and environmental exposure including UV rays and numerous pollutants. UV radiation stimulates the excessive generation of Reactive oxygen species (ROS) and Reactive nitrogen species (RNS), altering numerous signaling and inflammatory pathways and cumulatively causing alteration at numerous genetic and inflammatory levels. Numerous treatment strategies have been proposed for this purpose, and it has been found that antioxidants could play a crucial role in regulating inflammation at certain levels. Among numerous treatment strategies, natural flavonoid quercetin could play a vital role in protecting cells from oxidative stress as it is enriched with anticancer, antioxidant, and anti-inflammatory properties. The activities of quercetin could be further enhanced by administrating it through novel systems.

Objective: Thus, the present article focuses on the delivery of natural flavonoid quercetin via novel carrier noisome to enhance targeting potency and safety efficacy.

Method: Optimized quercetin-loaded niosomes were prepared by mechanical shaking method followed by solvent evaporation and altering the ratio of cholesterol and span 80. In vitro characterization was performed for morphology, zeta potential (ZP), entrapment efficiency and drug release.

Result: The optimized niosome was reported to have a size range of 120 nm, entrapment efficiency (80%-85%) and followed zero order kinetics.

Conclusion: Optimized quercetin-loaded niosomes were successfully formulated and characterized for controlled drug delivery.

Keywords: Skin cancer, quercetin, oxidative stress, niosomes, flavonoid, reactive oxygen species (ROS).

Graphical Abstract
[1]
Rodríguez S, Arenas M, Gutierrez C, et al. Recommendations of the Spanish brachytherapy group (GEB) of Spanish Society of Radiation Oncology (SEOR) and the Spanish Society of Medical Physics (SEFM) for high-dose rate (HDR) non melanoma skin cancer brachytherapy. Clin Transl Oncol 2018; 20(4): 431-42.
[http://dx.doi.org/10.1007/s12094-017-1733-z] [PMID: 28808925]
[2]
Narendhirakannan RT, Hannah MAC. Oxidative stress and skin cancer: an overview. Indian J Clin Biochem 2013; 28(2): 110-5.
[http://dx.doi.org/10.1007/s12291-012-0278-8] [PMID: 24426195]
[3]
Buchanan Lunsford N, Berktold J, Holman DM, Stein K, Prempeh A, Yerkes A. Skin cancer knowledge, awareness, beliefs and preventive behaviors among black and hispanic men and women. Prev Med Rep 2018; 12: 203-9.
[http://dx.doi.org/10.1016/j.pmedr.2018.09.017] [PMID: 30364862]
[4]
Xu D, Hu MJ, Wang YQ, Cui YL. Antioxidant activities of quercetin and its complexes for medicinal application. Molecules 2019; 24(6): 1123.
[http://dx.doi.org/10.3390/molecules24061123] [PMID: 30901869]
[5]
Srivastava NS, Srivastava RAK. Curcumin and quercetin synergistically inhibit cancer cell proliferation in multiple cancer cells and modulate Wnt/β-catenin signaling and apoptotic pathways in A375 cells. Phytomedicine 2019; 52: 117-28.
[http://dx.doi.org/10.1016/j.phymed.2018.09.224] [PMID: 30599890]
[6]
Park S, Lim W, Bazer FW, Whang KY, Song G. Quercetin inhibits proliferation of endometriosis regulating cyclin D1 and its target microRNAs in vitro and in vivo. J Nutr Biochem 2019; 63: 87-100.
[http://dx.doi.org/10.1016/j.jnutbio.2018.09.024] [PMID: 30359864]
[7]
Murakami A, Ashida H, Terao J. Multitargeted cancer prevention by quercetin. Cancer Lett 2008; 269(2): 315-25.
[http://dx.doi.org/10.1016/j.canlet.2008.03.046] [PMID: 18467024]
[8]
Yin Y, Li W, Son YO, et al. Quercitrin protects skin from UVB-induced oxidative damage. Toxicol Appl Pharmacol 2013; 269(2): 89-99.
[http://dx.doi.org/10.1016/j.taap.2013.03.015] [PMID: 23545178]
[9]
Pippa N, Naziris N, Stellas D, et al. PEO-b-PCL grafted niosomes: The cooperativilty of amphiphilic components and their properties in vitro and in vivo. Colloids Surf B Biointerfaces 2019; 177: 338-45.
[http://dx.doi.org/10.1016/j.colsurfb.2019.01.036] [PMID: 30772668]
[10]
Sandeep KS. Span-60 niosomal oral suspension of fluconazole: formulation and in vitro evaluation Asian J Pharm Res Health Care 2009; 1(2).
[11]
Kumar YP, Kumar KV, Shekar RR, Ravi M, Kishore VS. Formulation and evaluation of econazole niosomes. Sch Acad J Pharm 2013; 2(4): 315-8.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy